chr21-45994210-T-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_001848.3(COL6A1):āc.1379T>Cā(p.Val460Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000404 in 1,609,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001848.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A1 | NM_001848.3 | c.1379T>C | p.Val460Ala | missense_variant | 20/35 | ENST00000361866.8 | NP_001839.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A1 | ENST00000361866.8 | c.1379T>C | p.Val460Ala | missense_variant | 20/35 | 1 | NM_001848.3 | ENSP00000355180.3 | ||
COL6A1 | ENST00000683550.1 | n.154T>C | non_coding_transcript_exon_variant | 1/5 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 151964Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000667 AC: 16AN: 239710Hom.: 0 AF XY: 0.0000615 AC XY: 8AN XY: 130002
GnomAD4 exome AF: 0.0000254 AC: 37AN: 1457448Hom.: 0 Cov.: 33 AF XY: 0.0000179 AC XY: 13AN XY: 724500
GnomAD4 genome AF: 0.000184 AC: 28AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74344
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2022 | The c.1379T>C (p.V460A) alteration is located in exon 20 (coding exon 20) of the COL6A1 gene. This alteration results from a T to C substitution at nucleotide position 1379, causing the valine (V) at amino acid position 460 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 25, 2018 | - - |
Bethlem myopathy 1A Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 24, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at